Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

about

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

P2860

Q33795594-8E6B8B9B-6C51-4246-9304-2C4E6D9384DC Q47593445-47D3CC96-371B-4386-8E62-FBF459C39ACD

P2860

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

Item

http://www.wikidata.org/entity/Q37095730

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

@en

Modern Therapies for Idiopathic Inflammatory Myopathies

@nl

type

Item

label

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

@en

Modern Therapies for Idiopathic Inflammatory Myopathies

@nl

prefLabel

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

@en

Modern Therapies for Idiopathic Inflammatory Myopathies

@nl

P1476

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

@en

P2093

Chester V Oddis

http://www.w3.org/2001/XMLSchema#string

Rohit Aggarwal

http://www.w3.org/2001/XMLSchema#string

Siamak Moghadam-Kia

http://www.w3.org/2001/XMLSchema#string

P2860

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.

Tumor necrosis factor inhibitor-associated dermatomyositis

Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.

Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial.

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.

Azathioprine with prednisone for polymyositis. A controlled, clinical trial.

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

P2888

s12016-016-8530-2

P304

81-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-016-8530-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26767526

http://www.w3.org/2001/XMLSchema#string

P932

4945479

http://www.w3.org/2001/XMLSchema#string

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

about

P2860

P2860

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932